0001415889-24-007651.txt : 20240312
0001415889-24-007651.hdr.sgml : 20240312
20240312170216
ACCESSION NUMBER: 0001415889-24-007651
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240311
FILED AS OF DATE: 20240312
DATE AS OF CHANGE: 20240312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schall Thomas J.
CENTRAL INDEX KEY: 0001423084
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40675
FILM NUMBER: 24743137
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immuneering Corp
CENTRAL INDEX KEY: 0001790340
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 MAIN STREET, SECOND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-500-8080
MAIL ADDRESS:
STREET 1: 245 MAIN STREET, SECOND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
form4-03122024_090310.xml
X0508
4
2024-03-11
0001790340
Immuneering Corp
IMRX
0001423084
Schall Thomas J.
C/O IMMUNEERING CORPORATION
245 MAIN STREET, 2ND FLOOR
CAMBRIDGE
MA
02142
true
false
false
false
0
Stock Option
5.93
2024-03-11
4
A
0
35000
0
A
2034-03-11
Class A Common Stock
35000
35000
D
The option vests and becomes exercisable in equal monthly installments over a three year period commencing on April 11, 2024, and will be fully vested and exercisable on March 11, 2027.
/s/ Michael D. Bookman, Attorney-in-Fact for Thomas J. Schall
2024-03-12